Literature DB >> 27979017

Inhalation devices, delivery systems, and patient technique.

Harold S Nelson1.   

Abstract

BACKGROUND: In real-life clinical settings, physicians often consider the properties of various inhaled corticosteroids (ICSs), but typically little consideration is given to the properties of different inhalers and formulations.
OBJECTIVE: To discuss the effects of inhalation devices and user technique on efficacy, safety, and adherence with the aim of improving asthma management.
METHODS: Relevant publications were selected to augment discussion.
RESULTS: There are many types of devices available, each with advantages, disadvantages, ease of use, and rate of misuse. Aerosol particle size influences the deposition pattern of a drug in the lungs, and the optimal particle size range is 1 to 5 μm. Retrospective reviews suggest that smaller particles (1-2 μm) could provide improved asthma control, but randomized, prospective studies are needed. Multiple studies have demonstrated high misuse rates in patients for pressurized metered-dose inhalers and dry powder inhalers. Because of this, repeated education should include physical demonstrations of using the device, checking the patient's technique, correcting the technique, and rechecking the technique. This also means that dedicated, trained staff and placebo devices should be available for instructing patients. Furthermore, the device should be selected to be cost effective and to fit the patient's preference and ability to use it correctly to enhance compliance. Asthma management guidelines and algorithms are available to guide the clinician.
CONCLUSION: The choice of inhaler device should depend on cost effectiveness and the patient's preference and ability to use it correctly. Patient inhaler technique should be checked and, if necessary, corrected and rechecked, with retraining if needed, at every opportunity.
Copyright © 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27979017     DOI: 10.1016/j.anai.2016.05.006

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  4 in total

1.  Preclinical Development of Orally Inhaled Drugs (OIDs)-Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?

Authors:  Dania Movia; Adriele Prina-Mello
Journal:  Animals (Basel)       Date:  2020-07-24       Impact factor: 2.752

2.  Improved inhaler handling after repeated inhalation guidance for elderly patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Osamu Usami
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

3.  Efficacy and usability of a novel nebulizer targeting both upper and lower airways.

Authors:  Daniela Posa; Antonio Pizzulli; Petra Wagner; Serena Perna; Stephanie Hofmaier; Paolo Maria Matricardi; Susanne Lau
Journal:  Ital J Pediatr       Date:  2017-09-29       Impact factor: 2.638

Review 4.  Identifying Critical Errors: Addressing Inhaler Technique in the Context of Asthma Management.

Authors:  Sinthia Z Bosnic-Anticevich; Biljana Cvetkovski; Elizabeth A Azzi; Pamela Srour; Rachel Tan; Vicky Kritikos
Journal:  Pulm Ther       Date:  2018-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.